Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia.
Australian Center for NanoMedicine, UNSW Sydney, Sydney, NSW, Australia.
Biomater Sci. 2022 Oct 11;10(20):5876-5887. doi: 10.1039/d2bm00651k.
Understanding the underlying mechanisms of migration and metastasis is a key focus of cancer research. There is an urgent need to develop 3D tumor models that can mimic physiological cell-cell and cell-extracellular matrix interactions, with high reproducibility and that are suitable for high throughput (HTP) drug screening. Here, we developed a HTP 3D bioprinted migration model using a bespoke drop-on-demand bioprinting platform. This HTP platform coupled with tunable hydrogel systems enables (i) the rapid encapsulation of cancer cells within tumor mimicking matrices, (ii) and real-time measurement of cell movement, (iii) detailed molecular analysis for the study of mechanisms underlying cell migration and invasion, and (iv) the identification of novel therapeutic options. This work demonstrates that this HTP 3D bioprinted cell migration platform has broad applications across quantitative cell and cancer biology as well as drug screening.
了解迁移和转移的潜在机制是癌症研究的重点。迫切需要开发能够模拟生理细胞-细胞和细胞-细胞外基质相互作用的 3D 肿瘤模型,具有高重现性且适合高通量(HTP)药物筛选。在这里,我们使用定制的按需滴注生物打印平台开发了一种 HTP 3D 生物打印迁移模型。该 HTP 平台与可调节的水凝胶系统相结合,能够:(i)在肿瘤模拟基质中快速封装癌细胞,(ii)实时测量细胞运动,(iii)进行详细的分子分析,以研究细胞迁移和侵袭的机制,以及(iv)鉴定新的治疗选择。这项工作表明,这种 HTP 3D 生物打印细胞迁移平台在定量细胞和癌症生物学以及药物筛选方面具有广泛的应用。